These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 25088038)

  • 1. NEDD4: a promising target for cancer therapy.
    Ye X; Wang L; Shang B; Wang Z; Wei W
    Curr Cancer Drug Targets; 2014; 14(6):549-56. PubMed ID: 25088038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of SIRT1 by 17β-estradiol depends on ubiquitin-proteasome degradation of PPAR-γ mediated by NEDD4-1.
    Han L; Wang P; Zhao G; Wang H; Wang M; Chen J; Tong T
    Protein Cell; 2013 Apr; 4(4):310-21. PubMed ID: 23549616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NEDD4 E3 ubiquitin ligases: Promising biomarkers and therapeutic targets for cancer.
    Tian X; Chen Y; Peng Z; Lin Q; Sun A
    Biochem Pharmacol; 2023 Aug; 214():115641. PubMed ID: 37307883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HECT E3 ubiquitin ligase Nedd4-1 ubiquitinates ACK and regulates epidermal growth factor (EGF)-induced degradation of EGF receptor and ACK.
    Lin Q; Wang J; Childress C; Sudol M; Carey DJ; Yang W
    Mol Cell Biol; 2010 Mar; 30(6):1541-54. PubMed ID: 20086093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling the Potential Role of NEDD4-like E3 Ligases in Cancer.
    Jayaprakash S; Hegde M; BharathwajChetty B; Girisa S; Alqahtani MS; Abbas M; Sethi G; Kunnumakkara AB
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deubiquitinating enzyme inhibitors and their potential in cancer therapy.
    Crosas B
    Curr Cancer Drug Targets; 2014; 14(6):506-16. PubMed ID: 25088039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indole-3-carbinol (I3C) analogues are potent small molecule inhibitors of NEDD4-1 ubiquitin ligase activity that disrupt proliferation of human melanoma cells.
    Quirit JG; Lavrenov SN; Poindexter K; Xu J; Kyauk C; Durkin KA; Aronchik I; Tomasiak T; Solomatin YA; Preobrazhenskaya MN; Firestone GL
    Biochem Pharmacol; 2017 Mar; 127():13-27. PubMed ID: 27979631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of active ACK1 is mediated by association with the E3 ubiquitin ligase Nedd4-2.
    Chan W; Tian R; Lee YF; Sit ST; Lim L; Manser E
    J Biol Chem; 2009 Mar; 284(12):8185-94. PubMed ID: 19144635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of proteasome inhibitor-based anti-cancer therapies: perspective on bortezomib and second generation proteasome inhibitors versus future generation inhibitors of ubiquitin-proteasome system.
    Dou QP; Zonder JA
    Curr Cancer Drug Targets; 2014; 14(6):517-36. PubMed ID: 25092212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for E3-ubiquitin ligase inhibitors: challenges and opportunities.
    Landré V; Rotblat B; Melino S; Bernassola F; Melino G
    Oncotarget; 2014 Sep; 5(18):7988-8013. PubMed ID: 25237759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NEDD4 E3 Ligases: Functions and Mechanisms in Bone and Tooth.
    Xu K; Chu Y; Liu Q; Fan W; He H; Huang F
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium activates Nedd4 E3 ubiquitin ligases by releasing the C2 domain-mediated auto-inhibition.
    Wang J; Peng Q; Lin Q; Childress C; Carey D; Yang W
    J Biol Chem; 2010 Apr; 285(16):12279-88. PubMed ID: 20172859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SCF-type E3 Ubiquitin Ligases as Cancer Targets.
    Kitagawa K; Kitagawa M
    Curr Cancer Drug Targets; 2016; 16(2):119-29. PubMed ID: 26560120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitin-proteasome system (UPS) as a target for anticancer treatment.
    Park J; Cho J; Song EJ
    Arch Pharm Res; 2020 Nov; 43(11):1144-1161. PubMed ID: 33165832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological Functions of the Ubiquitin Ligases Nedd4-1 and Nedd4-2.
    Rotin D; Prag G
    Physiology (Bethesda); 2024 Jan; 39(1):18-29. PubMed ID: 37962894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional interaction of phosphatase and tensin homologue (PTEN) with the E3 ligase NEDD4-1 during neuronal response to zinc.
    Kwak YD; Wang B; Pan W; Xu H; Jiang X; Liao FF
    J Biol Chem; 2010 Mar; 285(13):9847-9857. PubMed ID: 20100827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NEDD4: The founding member of a family of ubiquitin-protein ligases.
    Boase NA; Kumar S
    Gene; 2015 Feb; 557(2):113-22. PubMed ID: 25527121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular functions of NEDD4 E3 ubiquitin ligases in cancer.
    Zou X; Levy-Cohen G; Blank M
    Biochim Biophys Acta; 2015 Aug; 1856(1):91-106. PubMed ID: 26116757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E3 Ubiquitin Ligases as Molecular Targets in Human Oral Cancers.
    Masumoto K; Kitagawa M
    Curr Cancer Drug Targets; 2016; 16(2):130-5. PubMed ID: 26560119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The E3 ubiquitin ligase NEDD4 negatively regulates HER3/ErbB3 level and signaling.
    Huang Z; Choi BK; Mujoo K; Fan X; Fa M; Mukherjee S; Owiti N; Zhang N; An Z
    Oncogene; 2015 Feb; 34(9):1105-15. PubMed ID: 24662824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.